Article
Characterization of N-terminal RYR2 variants outside CPVT1 hotspot regions using patient iPSCs reveal pathogenesis and therapeutic potential.
Stem cell reports - 13 Sept 2022
Stutzman Marissa J, Kim C S John, Tester David J, Hamrick Samantha K, Dotzler Steven M, Giudicessi John R, Miotto Marco C, Gc Jeevan B, Frank Joachim, Marks Andrew R, Ackerman Michael J
Abstract excerpt
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a cardiac channelopathy causing ventricular tachycardia following adrenergic stimulation. Pathogenic variants in RYR2-encoded ryanodine receptor 2 (RYR2) cause CPVT1 and cluster into domains I-IV, with the most N-terminal domain involving residues 77-466. Patient-specific induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) were generated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
